Efficacy and Safety of Concurrent Chemoradiotherapy as First‐Line Treatment for Stage <scp>IVB</scp> Cervical Cancer: A Single‐Center Retrospective Observational Study
Concurrent chemoradiotherapy may be a feasible first-line treatment option for stage IVB cervical cancer with manageable toxicity, acceptable disease control, and the potential to allow a timely transition to systemic chemotherapy.
Authors
- Takayoshi Iijima (ORCID: https://orcid.org/0000-0001-7459-7311)
- Yumi Ishidera (ORCID: https://orcid.org/0000-0001-7316-5728)
- Madoka Sugiura
- Masahiro Aichi (ORCID: https://orcid.org/0000-0003-0584-0810)
- Taichi Mizushima (ORCID: https://orcid.org/0000-0002-3505-4717)
- Etsuko Miyagi (ORCID: https://orcid.org/0000-0002-5492-0844)
- Yuichi Imai (ORCID: https://orcid.org/0000-0001-7347-9719)
- Masaharu Hata (ORCID: https://orcid.org/0000-0002-4133-2592)
- Yuki Ogawara
Institutions
- Yokohama City University (JP)
Publication Details
- Journal
- Journal of obstetrics and gynaecology research
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1111/jog.70119
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00